Innovative Multidisciplinary Research Pilot Award FY 25 Recipients

Frankel IHBH M-BoCA Awardees

The Stanley and Judith Frankel Institute for Heart and Brain Health and the Michigan-Biology of Cardiac Aging (M-BoCA) program of the Frankel Cardiovascular Center, are delighted to announce that the recipients of this year's Innovative Multidisciplinary Research Pilot Award are:

  • Andre Monteiro Da Rocha, Ph.D. (Internal Medicine – Cardiology) and Kenneth Cadigan, Ph.D. (Molecular, Cellular, and Developmental Biology) for their proposal: “Wnt and aging-associated diastolic dysfunction”
  • Matthias Truttmann, Ph.D. (Molecular and Integrative Physiology) and Andrea Thompson, MD, Ph.D. (Internal Medicine – Cardiology) for their proposal: “Novel FICD inhibitors to improve cardiomyocyte and motor neuron proteostasis”
FY 25 Awardees

“We are particularly excited to see these partnerships between investigators, as they represent exactly the kind of collaborative, cross-disciplinary work that will advance our understanding of brain and cardiac aging,” said Dr. Ahmed Abdel-Latif, Director of M-BoCA.  “We remain deeply committed to supporting early-career investigators and novel research directions in the biology of aging. These awards reflect our conviction that breakthrough discoveries often emerge from bold ideas and unexpected collaborations. We look forward to seeing how these projects develop and contribute to our understanding of heart and brain health."

The Innovative Multidisciplinary Research Pilot Award provides $100,000 annually for two years to support highly innovative research with the potential to substantively impact heart and brain health.

The objective of this pilot funding is to support projects that may be too innovative and speculative for traditional funding sources but still have a likelihood of producing impact findings. Aimed at encouraging compelling proposals across the full spectrum of our programmatic disciplines in support of innovative and impactful heart & brain research projects. We hope to support increased collaboration between experienced and new researchers to foster mentorship opportunities and knowledge exchange.  

Dr. Anthony Rosenzweig, Director of the Frankel IHBH commented, “It was a pleasure to partner with Dr. Abdel-Latif and the M-BOCA program of the Frankel Cardiovascular Center on these awards, which recognize the crucial role of aging in heart and brain disease. We are delighted to help support these innovative proposals and look forward to learning more as their science evolves.”

We will launch the Frankel IHBH Multidisciplinary Pilot Award FY 26 call for applications in June 2025.

Please contact our team with any questions or for additional information.

In This Story

Andre Monteiro Da Rocha, PhD

Andre Monteiro Da Rocha

Research Assistant Professor

Matthias C. Truttmann

Matthias Truttmann PhD

Associate Professor

profile-andrea-thompson-2020

Andrea D Thompson

Assistant Professor

Featured News & Stories

Woman's torso in a blue hospital gown, with her hands holding a pregnant belly and an IV in place.
Health Lab

High dose oxytocin protocol linked to lower postpartum hemorrhage rates

A change in how oxytocin is administered after childbirth may help reduce postpartum hemorrhage, a new study suggests.
Family with mom and dad and three kids sitting on a park bench, dad's arms extended around the family.
Health Lab

Intuition pushed mom to keep checking for breast cancer

Michigan mom had no reason to suspect cancer. But instinct nudged her to find out for sure — and carried her through challenging treatments to remission.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Jackie Yaho portrait
Research News

CMHC 2026 George L. Bakris Scholarship Program Recipient Zhiqi "Jackie" Yao, MD, ScM

Congratulations to 2026 George L. Bakris Scholarship Program Recipient Zhiqi "Jackie" Yao, MD, ScM.
Ambarish Pandey
Research News

Dr. Ambarish Pandey Presents at HFSA Annual Scientific Meeting

Dr. Ambarish Pandey presented findings from a Phase 1 clinical study at the Heart Failure Society of America (HFSA) Annual Scientific Meeting.
Santhi Ganesh
Department News

Connecting Genetics, Discovery and Patient Care: Dr. Santhi Ganesh on the Future of Vascular Genetic Medicine

As a cardiologist and physician-scientist, Dr. Ganesh has built her clinical and research career around understanding diseases that affect the structure and function of arteries. Her work focuses on vascular genetics and conditions including fibromuscular dysplasia (FMD), spontaneous coronary artery dissection (SCAD), pediatric renovascular hypertension, aneurysm and dissection syndromes, and other inherited or poorly understood arteriopathies.